Returned stocks to leave losses only to pharmacies.

Published: 2003-01-27 06:59:00

Updated: 2003-01-27 06:59:00

Most of drug makers did not comply to settle the return stocks from pharmacies in a cash but swap it to other general drugs, leaving a serious resistance from the pharmacy communities. Even some drug manufacturers refused to accept the returned goods from pharmacies or accepted only 70 to 80% of ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK